Seven Fleet Capital Management »

Contineum Therapeutics shares owned by Seven Fleet Capital Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Seven Fleet Capital Management from 13F filings

Historical chart of Seven Fleet Capital Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Seven Fleet Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Seven Fleet Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $353k 27k 13.06

More positions owned by Seven Fleet Capital Management

Cg Oncology
Tango Therapeutics (TNGX)
Revolution Medicines (RVMD)
Tyra Biosciences (TYRA)
Liquidia Corporation Com New (LQDA)
Agios Pharmaceuticals (AGIO)
Century Therapeutics (IPSC)
Enliven Therapeutics (ELVN)
Vaxcyte (PCVX)
Tango Therapeutics
Cogent Biosciences (COGT)
Avalo Therapeutics Com New
Minerva Neurosciences Com New
Cg Oncology (CGON)
Pharvaris N V (PHVS)

View all positions for Seven Fleet Capital Management

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Vanguard Group
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Sectoral Asset Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Contineum Therapeutics